CZDez: An oral chemotherapeutic regimen for the treatment of multiple myeloma.

被引：0
|
作者：
Moreton, P [1 ]
Morgan, GJ [1 ]
Cooke, G [1 ]
Hillmen, P [1 ]
Child, T [1 ]
机构：
[1] Gen Infirm, Acad Unit Haematol & Oncol, Leeds LS1 3EX, W Yorkshire, England
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4998
引用
收藏
页码：310B / 310B
页数：1
相关论文
共 50 条
  • [21] A novel candidate for immunologic target in treatment of multiple myeloma.
    Matsushita, Maiko
    Saito, Saku
    Mori, Kanae
    Yokoe, Shinya
    Ichikawa, Daiju
    Hattori, Yutaka
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (03) : 122 - 122
  • [22] A novel combination regimen for the treatment of multiple myeloma
    Nature Clinical Practice Oncology, 2008, 5 (5): : 242 - 242
  • [23] Pulsed cyclophosphamide, thalidomide and dexamethasone: Long term follow-up of an oral regimen for previously treated patients with multiple myeloma.
    Dimopoulos, MA
    Anagnostopoulos, A
    Hamilos, G
    Zomas, A
    Efstathiou, E
    Grigoraki, V
    Poziopoulos, C
    Gika, D
    Xilouri, I
    Zorzou, MP
    Anagnostopoulos, N
    BLOOD, 2003, 102 (11) : 148A - 149A
  • [24] Oral idarubicin as single agent therapy for patients with relapsed multiple myeloma.
    Sumpter, K
    Powles, R
    Raje, N
    Kulkarni, S
    Ramiah, V
    Hill, M
    Horton, C
    Milan, S
    Mehta, J
    Singhal, S
    Rodriguez, M
    Mateos, P
    Laufente, A
    Treleaven, J
    BLOOD, 1997, 90 (10) : 4144 - 4144
  • [25] Association of socioeconomic status with adherence to oral agents in patients with multiple myeloma.
    Rutter, Wilbur
    Prakash, Shivaani
    Cavers, William
    Avalos-Reyes, Elisea
    Johnson, Kjel Andrew
    Bernal-Mizrachi, Leon
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [26] Interphase FISH in multiple myeloma.
    Haaber, Jacob
    Sorensen, Anne G.
    Nibe, Anne
    Nielsen, Ole
    Abildgaard, Niels
    Plesner, Torben
    Kerndrup, Gitte B.
    BLOOD, 2006, 108 (11) : 344B - 344B
  • [27] Z-Dex (oral idarubicin and dexamethasone) is effective initial therapy in the treatment of patients with multiple myeloma.
    Cook, G
    Iqbal, A
    Russell, NH
    Samson, D
    Sharp, RA
    Tansey, P
    Franklin, IM
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 209 - 209
  • [28] Multiple myeloma. Epidemiology and staging
    Hillengass, J.
    Goldschmidt, H.
    ONKOLOGE, 2010, 16 (03): : 225 - +
  • [29] Lenalidomide use in multiple myeloma.
    Meade, Denise
    Ng, Marie
    Alford, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [30] Newly diagnosed multiple myeloma.
    Weber D.M.
    Current Treatment Options in Oncology, 2002, 3 (3) : 235 - 245
12345